Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preformulation studies on Freund's incomplete adjuvant emulsion.

R O Williams1, V Mahaguna

  • 1Pharmaceutics Division, College of Pharmacy, University of Texas, Austin, Texas 78712-1074, USA.

Drug Development and Industrial Pharmacy
|December 21, 2004
PubMed
Summary

Freund's Incomplete Adjuvant (FIA) preformulation studies show mannide monooleate effectively reduces interfacial tension in vaccine emulsions. Antigenic proteins like ovalbumin influence surface activity, impacting adjuvant formulation effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a low background liquid scintillation counter for a shallow underground laboratory.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2015
Same author

Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis.

Clinical and experimental immunology·2015
Same author

Blockade of tumour necrosis factor-α in experimental autoimmune encephalomyelitis reveals differential effects on the antigen-specific immune response and central nervous system histopathology.

Clinical and experimental immunology·2013
Same author

Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery.

International journal of pharmaceutics·2013
Same author

Atmospheric freeze drying for the reduction of powder electrostatics of amorphous, low density, high surface area pharmaceutical powders.

Drug development and industrial pharmacy·2012
Same author

What have we learnt from targeted anti-TNF therapy?

Annals of the rheumatic diseases·2009

Area of Science:

  • Pharmaceutical Sciences
  • Colloid and Surface Chemistry
  • Vaccine Formulation

Background:

  • Freund's Incomplete Adjuvant (FIA) is a critical water-in-oil emulsion for vaccine delivery.
  • Understanding the interfacial properties of FIA components is essential for optimizing vaccine efficacy.
  • Preformulation studies are key to characterizing the behavior of adjuvants and antigens within emulsions.

Purpose of the Study:

  • To investigate the preformulation characteristics of Freund's Incomplete Adjuvant (FIA) emulsions.
  • To determine the critical micelle concentration (CMC) and surface activity of mannide monooleate.
  • To assess the impact of ovalbumin and electrolytes on interfacial tension and surface activity in FIA.

Main Methods:

  • Utilized the DuNouy Ring Method to measure interfacial tension between oil and aqueous phases.

Related Experiment Videos

  • Determined critical micelle concentration (CMC) from surface tension versus concentration data.
  • Calculated surface excess concentration using the Gibbs' Adsorption equation.

    • Main Results:

    • Mannide monooleate demonstrated effective surface activity, indicated by a low CMC.
    • Both mannide monooleate and ovalbumin reduced interfacial tension between light mineral oil and aqueous phases.
    • Interfacial activity was influenced by the presence of electrolytes, proteins, and the surfactant itself.

    Conclusions:

    • Mannide monooleate is an effective surfactant for Freund's Incomplete Adjuvant (FIA) formulations.
    • Antigenic proteins in the aqueous phase can modulate the performance of surfactants in water-in-oil emulsions.
    • These findings provide crucial insights for the rational design of stable and effective vaccine adjuvants.